Skip to main content

Elena Sulleiro Igual

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca
Cap de Secció
Microbiology
Cross-departmental services

Elena Sulleiro Igual

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca
Cap de Secció
Microbiology
Cross-departmental services

Projects

Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Núria Pérez Picazo, Fernando M Salvador Velez, Tamara Del Rio Higueras, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Olga Sánchez- Maroto Carrizo, Janna Anthonina Slabbekoorn, Esperanza Esteban Serna
Funding agency: EUROPEAN COMMISSION
Funding: 939958.88
Reference: BERENICE_FP7HEALTH2012
Duration: 01/09/2012 - 31/08/2018

El diagnóstico parasitológico en una zona rural del África Subsahariana: proyecto de formación y colaboración con el Hospital Nossa Senhora da Paz en Cubal, Angola

IP: -
Collaborators: Elena Sulleiro Igual
Funding agency: Fundació ACMSCB-SC.
Funding: 3000
Reference: SCMIMC-2010-01
Duration: 01/10/2010 - 30/11/2010

Protocolo de ensayo clínico de fase II, aleatorizado y abierto para el tratamiento etiológico de la enfermedad de chagas crónica con posaconazol y benznidazol

IP: Albert Pahissa Berga
Collaborators: Maria Antònia Agustí Escasany, Israel Molina Romero, Inmaculada Fuentes Camps, Fernando M Salvador Velez, Jordi Gómez i Prat, Elena Sulleiro Igual
Funding agency: Ministerio Sanidad
Funding: 360687.3
Reference: TRA-201
Duration: 01/01/2010 - 31/12/2013

Grup d'Investigació en Microbiologia de l'Hospital Vall d'Hebron

IP: -
Collaborators: María Nieves Larrosa Escartin, Gema Codina Grau, Rosa María Bartolomé Comas, Mª Teresa Tórtola Fernández, Elena Sulleiro Igual, Juan Jose Gonzalez Lopez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 42640
Reference: 2009 SGR 296
Duration: 01/01/2010 - 30/04/2014

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

Miquel Masachs Peracaula

Miquel Masachs Peracaula

Read more
Marta Perez  Peña

Marta Perez Peña

Predoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.